PT - JOURNAL ARTICLE AU - The COVID-19 Host Genetics Initiative AU - Andrea Ganna TI - Mapping the human genetic architecture of COVID-19 by worldwide meta-analysis AID - 10.1101/2021.03.10.21252820 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.10.21252820 4099 - http://medrxiv.org/content/early/2021/05/08/2021.03.10.21252820.short 4100 - http://medrxiv.org/content/early/2021/05/08/2021.03.10.21252820.full AB - The genetic makeup of an individual contributes to susceptibility and response to viral infection. While environmental, clinical and social factors play a role in exposure to SARS-CoV-2 and COVID-19 disease severity, host genetics may also be important. Identifying host-specific genetic factors indicate biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-COV-2 infection and COVID-19 severity. We describe the results of three genome-wide association meta-analyses comprising up to 49,562 COVID-19 patients from 46 studies across 19 countries worldwide. We reported 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases. They also represent potentially actionable mechanisms in response to infection. We further identified smoking and body mass index as causal risk factors for severe COVID-19. The identification of novel host genetic factors associated with COVID-19, with unprecedented speed, was enabled by prioritization of shared resources and analytical frameworks. This working model of international collaboration provides a blue-print for future genetic discoveries in the event of pandemics or for any complex human disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPlease refer to Supplementary Table 1 for information regarding individual studies involved in the COVID-19 Host Genetics Initiative.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Please refer to Supplementary Table 1 for information regarding individual studies involved in the COVID-19 Host Genetics Initiative.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics generated by COVID-19 HGI are available at https://www.covid19hg.org/results/r5/ and will be made available on GWAS Catalog. The analyses described here utilize the freeze 5 data. COVID-19 HGI continues to regularly release new data freezes. Summary statistics for non-European ancestry samples are not currently available due to the small individual sample sizes of these groups. Summary statistics liftover and meta-analysis and PCA pipeline code is available at https://github.com/covid19-hg/ and code for Mendelian randomization and genetic correlation pipeline at https://github.com/marcoralab/MRcovid. https://www.covid19hg.org/results/r5/ https://github.com/covid19-hg/ https://github.com/marcoralab/MRcovid